Our primary objective is to develop a clinical pathway for care of patients having colorectal surgery at the Clinic. In particular, the investigators would like to determine what intraoperative concentration of oxygen is optimal in our patients. The investigators therefore propose to test the primary hypothesis that supplemental oxygen (80% versus 30%) reduces the risk of a composite of surgical sites infection and potentially oxygen-related wound complications. Secondarily, the investigators will assess the incremental cost benefit of 80% versus 30% oxygen. As a safety measure, enough oxygen will always be given to maintain oxygen saturation (as determined by pulse oximetry) ≥95%.

Our primary objective is to develop a clinical pathway for care of patients having colo-rectal surgery at the Clinic. In particular, we would like to determine what intraoperative concentration of supplemental oxygen (30% or 80%)is optimal in our patients. As a safety measure, enough oxygen will always be given to maintain oxygen saturation (as determined by pulse oximetry) ≥95%.

Operating room will be maintained at 30% oxygenation during colorectal surgery.

Other: 30% oxgen

Operating room will be maintained at 30% oxygenation during colorectal surgery.

80 % oxygen

Operating room will be maintained at 80% oxygenation during colorectal surgery.

Other: 80% oxygen

Operating room will be maintained at 80% oxygenation.

Eligibility

Ages Eligible for Study:

18 Years to 80 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Sampling Method:

Non-Probability Sample

Study Population

adult colorectal surgical patients

Criteria

Inclusion Criteria:

adult colorectal surgical patients

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01777568